Načítá se...
Cytomegalovirus Infection after CD34(+) Selected Hematopoietic Cell Transplant
BACKGROUND: The effectiveness of preemptive treatment (PET) for CMV in recipients of ex vivo T-cell depleted (TCD) hematopoietic cell transplantation (HCT) by CD34(+) selection is not well defined. METHODS: We analyzed 213 adults who received TCD-HCT at our institution from June 2010 through May 201...
Uloženo v:
Vydáno v: | Biol Blood Marrow Transplant |
---|---|
Hlavní autoři: | , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4949094/ https://ncbi.nlm.nih.gov/pubmed/27178374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.05.003 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|